219 POSTER NVP-BEZ235, a dual pan-PI3K/mTOR kinase inhibitor, is effective in human lung cancer models harboring EGFR mutations

2008 ◽  
Vol 6 (12) ◽  
pp. 69
Author(s):  
C.R. Schnell ◽  
J. Vaxelaire ◽  
M. Vogelsanger ◽  
M. Hattenberger ◽  
F. Stauffer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Human Lung ◽  
Kinase Inhibitor ◽  
Human Lung Cancer ◽  
Egfr Mutations ◽  
Mtor Kinase ◽  
Cancer Models

scholarly journals Use of Bioengineered Rat Lungs for Novel Ex Vivo Human Lung Cancer Models

2020 ◽  
Author(s):  
S. Mizoguchi ◽  
T. Tsuchiya ◽  
M. Ishii ◽  
R. Doi ◽  
H. Watanabe ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Human Lung ◽  
Ex Vivo ◽  
Human Lung Cancer ◽  
Rat Lungs ◽  
Cancer Models

scholarly journals Combined MEK and VEGFR Inhibition in Orthotopic Human Lung Cancer Models Results in Enhanced Inhibition of Tumor Angiogenesis, Growth, and Metastasis

2012 ◽  
Vol 18 (6) ◽  
pp. 1641-1654 ◽  
Author(s):  
Osamu Takahashi ◽  
Ritsuko Komaki ◽  
Paul D. Smith ◽  
Juliane M. Jürgensmeier ◽  
Anderson Ryan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tumor Angiogenesis ◽  
Human Lung ◽  
Human Lung Cancer ◽  
Cancer Models

scholarly journals FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor

Oncotarget ◽  
2014 ◽  
Vol 5 (15) ◽  
pp. 5908-5919 ◽  
Author(s):  
Koichi Azuma ◽  
Akihiko Kawahara ◽  
Kahori Sonoda ◽  
Kazutaka Nakashima ◽  
Kousuke Tashiro ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Cells ◽  
Human Lung ◽  
Kinase Inhibitor ◽  
Lung Cancer Cells ◽  
Human Lung Cancer ◽  
Escape Mechanism ◽  
Human Lung Cancer Cells ◽  
Egfr Family

Ras Denitrosylation in Human Lung Cancer

2012 ◽  
Vol 3 (2) ◽  
pp. 135-139
Author(s):  
Benjamin Gaston ◽  
Nadzeya Marozkina
Keyword(s):  
Lung Cancer ◽  
Human Lung ◽  
Human Lung Cancer
Sign in / Sign up

Export Citation Format

Share Document